PMGC (ELAB) Stock Price, News & Analysis

Company Overview

PMGC (NASDAQ:ELAB) is a global provider of laboratory and diagnostic solutions supporting the life sciences, pharmaceutical research and clinical markets. The company designs, manufactures and distributes a diversified portfolio of instruments, reagents and consumables aimed at accelerating research and improving laboratory efficiency. PMGC’s offerings span from benchtop analyzers to fully integrated automated systems, complemented by data analytics and informatics platforms.

At the core of PMGC’s business are its proprietary technologies for sample preparation, biomolecular assays and high-throughput screening. The company’s reagent lines cover genomic, proteomic and cell-based applications, while its hardware platforms enable precise temperature control, fluorescence detection and real-time monitoring. PMGC also provides a suite of laboratory information management systems (LIMS) and cloud-based software to streamline workflow management and ensure data integrity.

Founded in 1986 and headquartered in Chicago, Illinois, PMGC has developed a global presence with research and manufacturing facilities in North America, Europe and Asia-Pacific. Through a combination of organic growth and strategic acquisitions, the company has expanded its distribution channels to serve academic institutions, pharmaceutical companies and clinical diagnostic labs in over 70 countries. PMGC’s international footprint is supported by a network of regional sales and service teams, as well as partnerships with third-party distributors.

Under the leadership of CEO Dr. Alexandra Langford, PMGC continues to invest in research and development to address emerging trends in precision medicine and personalized diagnostics. The company’s management team brings together expertise in biochemistry, engineering and software development, positioning PMGC to capitalize on growing demand for integrated laboratory solutions. With a focus on innovation and operational excellence, PMGC aims to drive long-term growth by delivering high-value products and services to its global customer base.

Key Stats

• Today's Range: $2.23 to $2.23
• 50-Day Range: $2.04 to $2.64
• 52-Week Range: $1.95 to $756.00
• Volume: 1,342 shs
• Average Volume: 385,668 shs
• Market Capitalization: $3.08 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

PMGC Stock Analysis - MarketRank™

PMGC scored higher than 12% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: N/A
• Analyst Rating: N/A

Consensus Rating

There is not enough analysis data for PMGC.

Earnings and Valuation

• Score: 0.6 / 5
• Proj. Earnings Growth: N/A

Price to Earnings Ratio vs. the Market

The P/E ratio of PMGC is -0.01, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Ratio vs. Sector

The P/E ratio of PMGC is -0.01, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Book Value per Share Ratio

PMGC has a P/B Ratio of 0.19. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

Short Interest

• Score: 4.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

10.58% of the float of PMGC has been sold short.

Short Interest Ratio / Days to Cover

PMGC has a short interest ratio ("days to cover") of 0.2, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in PMGC has recently decreased by 34.54%, indicating that investor sentiment is improving significantly.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

PMGC does not currently pay a dividend.

Dividend Growth

PMGC does not have a long track record of dividend growth.

Sustainability and ESG

• Score: N/A
• Environmental Score: N/A

Percentage of Shares Shorted

10.58% of the float of PMGC has been sold short.

Short Interest Ratio / Days to Cover

PMGC has a short interest ratio ("days to cover") of 0.2, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in PMGC has recently decreased by 34.54%, indicating that investor sentiment is improving significantly.

News and Social Media

• Score: 1.9 / 5
• News Sentiment: 0.48

News Sentiment

PMGC has a news sentiment score of 0.48. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.95 average news sentiment score of Multi-Sector Conglomerates companies.

News Coverage This Week

MarketBeat has tracked 7 news articles for PMGC this week, compared to 1 article on an average week.

Company Ownership

• Score: 0.0 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, PMGC insiders have not sold or bought any company stock.

Percentage Held by Insiders

Only 0.60% of the stock of PMGC is held by insiders.

Percentage Held by Institutions

Only 22.22% of the stock of PMGC is held by institutions.

ELAB Stock Analysis - Frequently Asked Questions

How have ELAB shares performed this year?

PMGC's stock was trading at $16.03 on January 1st, 2025. Since then, ELAB shares have decreased by 86.0% and is now trading at $2.24.

How were PMGC's earnings last quarter?

PMGC Holdings Inc. (NASDAQ:ELAB) released its earnings results on Wednesday, May, 14th. The company reported ($2.90) EPS for the quarter.

When did PMGC's stock split?

PMGC shares reverse split on the morning of Monday, March 10th 2025.A 1-7 reverse split was announced. The number of shares owned by shareholders was adjusted after the market closes on Sunday, March 9th 2025. An investor that had 100 shares of stock prior to the reverse split would have 14 shares after the split.

When did PMGC IPO?

PMGC (ELAB) raised $6 million in an IPO on Tuesday, November 21st 2023. The company issued 1,500,000 shares at $4.00 per share. Univest Securities served as the underwriter for the IPO.

How do I buy shares of PMGC?

Shares of ELAB stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of PMGC own?

Based on aggregate information from My MarketBeat watchlists, some other companies that PMGC investors own include BIOLASE (BIOL), Conduit Pharmaceuticals (CDT), Cyclacel Pharmaceuticals (CYCC), Dare Bioscience (DARE), TRACON Pharmaceuticals (TCON), Tempest Therapeutics (TPST) and 22nd Century Group (XXII).

Company Calendar

• Last Earnings: 5/14/2025
• Today: 7/14/2025
• Next Earnings (Estimated): 8/13/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Multi-Sector Conglomerates
• Industry: DIVERSIFIED OPS
• Sub-Industry: Pharmaceutical Products
• Current Symbol: NASDAQ:ELAB
• Previous Symbol: NASDAQ:ELAB
• CIK: 1840563
• Web: elevaiskincare.com
• Phone: 866-794-4940
• Fax: N/A
• Employees: 18
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): ($433.87)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -$6.25 million
• Net Margins: N/A
• Pretax Margin: -505,406.53%
• Return on Equity: -77.80%
• Return on Assets: -59.17%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 8.97
• Quick Ratio: 8.97

Sales & Book Value

• Annual Sales: $1.71 million
• Price / Sales: 1.78
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: $11.53 per share
• Price / Book: 0.19

Miscellaneous

• Outstanding Shares: 1,380,000
• Free Float: 1,367,000
• Market Cap: $3.05 million
• Optionable: N/A
• Beta: 0.13